{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:11:44Z","timestamp":1780920704210,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":97,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101211","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:58:11Z","timestamp":1775667491000},"page":"101211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-101X","authenticated-orcid":false,"given":"Lianfang","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101211_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103951","article-title":"Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: a population-based study","volume":"78","author":"Zhou","year":"2022","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101211_bib0002","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1470-2045(16)30069-9","article-title":"Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomized, controlled NELSON trial","volume":"17","author":"Walter","year":"2016","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101211_bib0003","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early-stage lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101211_bib0004","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101211_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.athoracsur.2023.01.014","article-title":"Ten-year follow-up results of pure ground-glass opacity-featured lung adenocarcinomas after surgery","volume":"116","author":"Li","year":"2023","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101211_bib0006","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/0284186X.2017.1390250","article-title":"The risk of second primary malignancy in patients with stage ia non-small cell lung cancer: a U.S. population-based study","volume":"57","author":"Khanal","year":"2018","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ctarc.2026.101211_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107218","article-title":"Risk-based screening for second primary extrapulmonary malignancies in stage I lung cancer patients: a study based on SEER database","volume":"180","author":"Wang","year":"2023","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101211_bib0008","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jtho.2017.09.1964","article-title":"Risk of second lung cancer in patients with previously treated lung cancer: analysis of surveillance, epidemiology, and end results (SEER) data","volume":"13","author":"Thakur","year":"2018","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101211_bib0009","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.radonc.2016.08.017","article-title":"Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: a systematic review and meta-analysis of population-based studies including 522,739 patients","volume":"121","author":"Grantzau","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2026.101211_bib0010","doi-asserted-by":"crossref","first-page":"i851","DOI":"10.1136\/bmj.i851","article-title":"Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis","volume":"352","author":"Wallis","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101211_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12967-022-03857-y","article-title":"Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study","volume":"21","author":"Zhou","year":"2023","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101211_bib0012","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.21037\/jtd-21-915","article-title":"Long-term radiation therapy-related risk of second primary malignancies in patients with lung cancer","volume":"13","author":"Han","year":"2021","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101211_bib0013","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/cancers15051431","article-title":"Real-world impact of SABR on stage I non-small-cell lung cancer outcomes at a Scottish cancer centre","volume":"15","author":"Stares","year":"2023","journal-title":"Cancer. (Basel)"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101211_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.cllc.2015.09.006","article-title":"Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: implications for surveillance","volume":"17","author":"Spratt","year":"2016","journal-title":"Clin. Lung Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101211_bib0015","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1016\/j.cllc.2021.11.004","article-title":"Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer","volume":"23","author":"Aldin","year":"2022","journal-title":"Clin. Lung Cancer"},{"issue":"3\u20134","key":"10.1016\/j.ctarc.2026.101211_bib0016","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.wneu.2013.10.043","article-title":"Secondary neoplasms after stereotactic radiosurgery","volume":"81","author":"Patel","year":"2014","journal-title":"World Neurosurg."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101211_bib0017","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1088\/0031-9155\/60\/3\/1237","article-title":"Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy","volume":"60","author":"Murray","year":"2015","journal-title":"Phys. Med. Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101211_bib0018","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jrr\/rrab038","article-title":"Secondary cancer risk from modern external-beam radiotherapy of prostate cancer patients: impact of fractionation and dose distribution","volume":"62","author":"Sitathanee","year":"2021","journal-title":"J. Radiat. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101211_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(18)30659-4","article-title":"Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study","volume":"20","author":"Wolf","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101211_bib0020","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fbioe.2020.00306","article-title":"Radiation-induced secondary cancer risk assessment in patients with lung cancer after stereotactic body radiotherapy using the CyberKnife M6 system with lung-optimized treatment","volume":"8","author":"Chao","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101211_bib0021","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in oncology","volume":"22","author":"Riely","year":"2024","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101211_bib0022","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jgo.2019.05.002","article-title":"Prognostic value of two geriatric screening tools in a cohort of older patients with early stage Non-small cell lung cancer treated with hypofractionated stereotactic radiotherapy","volume":"11","author":"Cuccia","year":"2020","journal-title":"J. Geriatr. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:47:52Z","timestamp":1780919272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"alternative-id":["S246829422600122X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101211","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101211"}}